Indivior Plc to delist from London Stock Exchange, citing U.S. focus and cost savings
RICHMOND: Indivior PLC (Nasdaq/LSE: INDV) announced Tuesday its plans to cancel its secondary listing on the London Stock Exchange, consolidating its primary listing on Nasdaq as the company shifts focus to its U.S. operations. The pharmaceutical firm, known for its…